Efficacy of Rivaroxaban for thromboprophylaxis after Knee Arthroscopy (ERIKA)
Giuseppe Camporese(University of Padua), Giancarlo Agnelli(University of Perugia), Franco Noventa(University of Padua), Matteo Marullo(Istituto Clinico Sant'Ambrogio), Michela Nardin(Ospedale Civile di Venezia), L. Santoro(Università Cattolica del Sacro Cuore), Claudio Mazzola(Ente Ospedaliero Ospedali Galliera), G Damiani(Ente Ospedaliero Ospedali Galliera), Cristiano Bortoluzzi(Ospedale Civile di Venezia), Giuseppe Monteleone(Università Cattolica del Sacro Cuore), Pietro Maniscalco(Ospedaliera di Piacenza), Cecilia Becattini(University of Perugia), Enrico Bernardi(Amsterdam UMC Location University of Amsterdam), Giacomo Zanon(University of Pavia), Davide Imberti, Chiara Tonello(University of Padua), Stefano Freguja(Thetis), Mario Bosco(ASL Roma), Corrado Lodigiani(Humanitas University)
Cited by 33
Related Papers
Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis
|Blood|2002|1.9k
Morbidity and mortality in compensated cirrhosis type C: A retrospective follow-up study of 384 patients
|Gastroenterology|1997|1.4k
A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score
|Journal of Thrombosis and Haemostasis|2010|1.2k
The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients
|Haematologica|2007|774
A Clinical Outcome-Based Prospective Study on Venous Thromboembolism After Cancer Surgery
|Annals of Surgery|2005|688